Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMP0NW3)

Drug Name

2-phenyl-N-(thiazol-2-yl)acetamide Drug Info

Synonyms

2-Phenyl-N-(1,3-thiazol-2-yl)acetamide; 2-Phenyl-N-thiazol-2-yl-acetamide; 292051-66-2; Benzeneacetamide, N-2-thiazolyl-; BAS 15431504; ChemDiv2_003476; AC1LBQ73; MLS001211116; CHEMBL227897; SCHEMBL4687548; ZINC29573; HYRZQLIFVQELLP-UHFFFAOYSA-N; MolPort-001-012-138; HMS2829M16; HMS1378N22; STK012295; AKOS000714854; MCULE-4931151694; ST042627; SMR000516648; 2-Phenyl-N-(1,3-thiazol-2-yl)acetamide #; 2-phenyl-N~1~-(1,3-thiazol-2-yl)acetamide; SR-01000415900; SR-01000415900-1; BRD-K98487211-001-07-7; Z28173686

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 562362
TTD Drug ID: DMP0NW3

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
LOX-5 messenger RNA (ALOX5 mRNA)	TTSJ6Q4	LOX5_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
LOX-5 messenger RNA (ALOX5 mRNA)	DTT	ALOX5	4.966	5.133	5.358	6.128

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
LOX-5 messenger RNA (ALOX5 mRNA)	DTT	ALOX5	9.43E-03	0.14	0.28

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6.